To further explore the role of the CXCL1/CXCR2 axis in DN development, repertaxin (a previously reported CXCR2 inhibitor) was used to block the CXCL1/CXCR2 axis in db/db mice. The gene discussed is CXCL1; the disease is liver dysplastic nodule.